The information provided on this site is intended only for healthcare professionals in the United States.*
*The products discussed herein may have different product labeling in different countries.
When every second counts- will your patient have impavido in time?
How to Enroll:
Complete and email Consignment agreement located Below to
Features & Benefits
On Hand Supply of Product: Hospital eliminates emergencies, product outdating or overstocking
Low Cost Solution: Small delivery fee allows for peace of mind.
Essential Medicines WHO Model List : Impavido (miltefosine) is on the list of minimum medicine needs for a basic health‐care system.
The WHO Model list for a basic health-care system lists the most efficacious, safe and cost‐effective medicines for priority conditions.
Priority conditions are selected on the basis of current and estimated future public health relevance and potential for safe and cost‐effective treatment.
CALL PROFOUNDA AT 407-270-7790 to Learn More
21 Hospitals Carry Impavido On-site.
Hospitals with Impavido on-site for Immediate Use:
Cook Children’s Medical Center Fort Worth TX 76104
Childrens Medical Center Dallas Dallas TX 75235
Palmetto Health Richland Columbia SC 29203
James A. Haley VA Medical Center Tampa FL 33612
Carolina Medical Center Charlotte NC 28203
Orlando Health Orlando FL 32806
Johns Hopkins All Children's Hospital St. Petersburg, FL 33701
UPMC Presbyterian Shadyside Pittsburgh PA 15203
Texas Childrens Hospital Houston TX 77030
U of MN Medical Center Fairview Minneapolis MN 55454
Tampa General Hospital Tampa FL 33606
Lee Memorial Health System Fort Myers FL 33908
University Health Shreveport Shreveport LA 71103
Shands Teaching Hospital & Clinics Gainesville FL 32610
Nebraska Medicine Omaha NE 68198
Lakeland Regional Medical Center, Lakeland, FL 33805
Nicklaus Children's Hospital, Miami, FL 33155
Nemours Childrens Hospital, Orlando, FL 32827
Joe DiMaggio Childrens Hospital,Hollwood FL 33021
Arkansas Children's Hospital, Little Rock, AR 72202
Pomona Valley Hospital Medical Center, Pomona, CA 91767
What Is the Program?
Impavido, like other orphan drugs for rare diseases, is expensive. It carries a high cost as the number of patients needing treatment in the United States is small.
By offering a risk sharing consignment inventory program, Profounda hopes to have the product available at more locations so that, when needed, the product may be available for use without unnecessary further delays.
The program is simple.
STEP 1: Hospitals enroll in Orphan Drugs On Site Program by signing Profounda's consignment agreement. The consignement agreement is free other than $100 shipping charge.
Step 2: The Hospital receives consigned Inventory- but the title remains with Profounda
Step 3: Hospital notifies Profounda when product is used and receives final invoice for said used product.
Step 4: Replacement product is sent to maintain inventory at hospital.
Step 4: If no product used, by expiration date product is returned to Profounda and replacement product with newer dating is sent back to the Hospital. If product is not returned, an invoice will be generated.
Contact Your Doctor or the CDC to Learn More about IMPAVIDO (miltefosine)
Impavido is a registered trademark of Knight Therapeutics Licensed exclusively to Profounda in the USA
© 2015 Profounda, Inc.
Impavido® (miltefosine) is an FDA-approved treatment for cutaneous, mucosal and visceral leishmaniasis in patients 12 years of age and older. PLEASE SEE FULL PRESCRIBING INFO